Recetas Pharmacy Inc
Community/Retail Pharmacy
112 E 183rd St, Bronx
New York, 10453-1237
718-733-9330 718-329-2717
Recetas Pharmacy Inc is a Community/Retail Pharmacy in Bronx, New York. It is located at 112 E 183rd St, Bronx and it's customer support contact number is 718-733-9330. The authorized person of Recetas Pharmacy Inc is Anthony Saba, SPI who is President of the pharmacy and his contact number is 718-733-9330. Active license number of Recetas Pharmacy Inc is 014392 for Community/Retail Pharmacy in New York. Recetas Pharmacy Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Recetas Pharmacy Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Recetas Pharmacy Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Recetas Pharmacy Inc |
| Type: | Community/Retail Pharmacy |
| Location: | 112 E 183rd St, Bronx,
New York, 10453-1237 |
| Phone: | 718-733-9330 |
| Fax: | 718-329-2717 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Anthony Saba |
| Credentials: | SPI |
| Position: | President |
| Contact Number: | 718-733-9330 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1639101470 |
| NPI Enumeration Date: | 06 Jul, 2006 |
| NPI Last Update On: | 13 Sep, 2007 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Recetas Pharmacy Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 014392 | New York | Primary | |
| Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 00266197 | Medicaid | New York | |
| 3322497 | Other | | Other Id Number |
Medicare Enrollment:
Recetas Pharmacy Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 3678694593 | O20100930091223 | Recetas Pharmacy Inc | DME SUPPLIER - PHARMACY |
Products Available:
Recetas Pharmacy Inc has following products available for sale under medicare.
| Products: |
|---|
| • Blood Glucose Monitors & Supplies: Non-mail Order | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 112 E 183rd St,
Bronx, New York |
| Zip: | 10453-1237 |
| Phone Number: | -- |
Patients can reach Recetas Pharmacy Inc at
112 E 183rd St, Bronx, New York or can
call on customer care at 718-733-9330.
Comments/ Reviews:
Read all the reviews posted for Recetas Pharmacy Inc below. You may also share your own experience with Recetas Pharmacy Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.